Ipca Laboratories Q1 PAT may dip 36.5% YoY to Rs 194.9 cr: Prabhudas Lilladher

Ipca Lab to merge two units with itself. Ipca Laboratories said its board approved merging Tonira Exports Ltd. and Ramdev Chemical Pvt. Ltd., wholly owned subsidiaries with the Company, subject to necessary approvals. The firm earlier reported consolidated net profit that fell 19.3% YoY to Rs 130.23 crore. Revenue rose 15.6% from a year ago to Rs 1,289.10 crore in the quarter.

Trade

• Watchlist
• Portfolio
• Message
• Set Alert

 

 

Choose Stock Exchange: BSE LIVE NSE LIVE

26 Aug, 2025 12:21

Volume

Todays L/H

More

×

Prabhudas Lilladher has come out with its first quarter (April-June’ 22) earnings estimates for the Healthcare sector. The brokerage house expects Ipca Laboratories to report net profit at Rs 194.9 crore down 36.5% year-on-year (up 49.6% quarter-on-quarter).

Net Sales are expected to decrease by 7.3 percent Y-o-Y (up 12.6 percent Q-o-Q) to Rs 1,451.7 crore, according to Prabhudas Lilladher.

Earnings before interest, tax, depreciation and amortisation (EBITDA) are likely to fall by 25.3 percent Y-o-Y (up 39.3 percent Q-o-Q) to Rs 308.6 crore.

Disclaimer: The views and investment tips expressed by investment experts on moneycontrol.com are their own, and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.

Healthcare